Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
You state eGFR was non-significant at p = .4 yet BearDwnAZ said this:
They all say the same thing. In the rather small post-hoc analysis of 48 CKD patients from combined SUSTAIN (24-week study) and ASSURE (26-week study), there were 13 placebo and 35 apabetalone patients. The apabetalone group increased eGFR by 3.4% vs. baseline, which was significant (p=0.04).
